These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11070769)

  • 1. [Septic-toxic shock due to rhabdomyolysis in a patient treated with fenofibrate].
    Duda-Król W; Jórasz I; Dabrowska M; Polubiec A; Kusz-Rynkun A
    Wiad Lek; 2000; 53(7-8):454-7. PubMed ID: 11070769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute renal failure secondary to fenofibrate monotherapy-induced rhabdomyolysis.
    Tahmaz M; Kumbasar B; Ergen K; Ure U; Karatemiz G; Kazancioglu R
    Ren Fail; 2007; 29(7):927-30. PubMed ID: 17994463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis caused by Commiphora mukul, a natural lipid-lowering agent.
    Bianchi A; Cantù P; Firenzuoli F; Mazzanti G; Menniti-Ippolito F; Raschetti R
    Ann Pharmacother; 2004; 38(7-8):1222-5. PubMed ID: 15187214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
    Jones PH; Davidson MH
    Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynecomastia associated with fenofibrate.
    Gardette V; Vezzosi D; Maiza JC; Montastruc JL; Olivier P
    Ann Pharmacother; 2007 Mar; 41(3):508-10. PubMed ID: 17341535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Necrotizing myopathy with antilipemic agents. Case report and review of the literature].
    Berger O; Zifko U; Jellinger K; Machacek E; Grisold W
    Nervenarzt; 1993 Aug; 64(8):539-44. PubMed ID: 8413753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare side-effects of fenofibrate.
    Rabasa-Lhoret R; Rasamisoa M; Avignon A; Monnier L
    Diabetes Metab; 2001 Feb; 27(1):66-8. PubMed ID: 11240449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal rhabdomyolysis caused by lipid-lowering therapy.
    Federman DG; Hussain F; Walters AB
    South Med J; 2001 Oct; 94(10):1023-6. PubMed ID: 11702815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myopathy caused by a combination rosuvastatin and fenofibrate.
    Dedhia V; Munsi SC
    J Assoc Physicians India; 2007 Feb; 55():152-3. PubMed ID: 17571748
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypothyroidism, hypocholesteremic agents and rhabdomyolysis].
    Gouton M
    Arch Mal Coeur Vaiss; 1993 Dec; 86(12):1761-4. PubMed ID: 8024378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate can increase serum creatinine levels in renal insufficiency.
    Paul S; Mohan V
    J Assoc Physicians India; 2006 Apr; 54():337. PubMed ID: 16944623
    [No Abstract]   [Full Text] [Related]  

  • 12. Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy.
    Layne RD; Sehbai AS; Stark LJ
    Ann Pharmacother; 2004 Feb; 38(2):232-4. PubMed ID: 14742756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure in toxic shock syndrome owing to rhabdomyolysis.
    Bachhuber R; Parker RA; Bennett WM
    Ann Clin Lab Sci; 1983; 13(1):25-6. PubMed ID: 6838149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rhabdomyolysis and anuric kidney failure induced by the treatment with a gemfibrozil-cerivastatin combination].
    Sirvent AE; Cabezuelo JB; Enríquez R; Amorós F; González C; Reyes A
    Nefrologia; 2001; 21(5):497-500. PubMed ID: 11795020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for statin-associated rhabdomyolysis.
    Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate-associated reversible acute allograft dysfunction in 3 renal transplant recipients: biopsy evidence of tubular toxicity.
    Angeles C; Lane BP; Miller F; Nord EP
    Am J Kidney Dis; 2004 Sep; 44(3):543-50. PubMed ID: 15332227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin-induced rhabdomyolysis in a CsA-treated renal transplant recipient.
    Gumprecht J; Zychma M; Grzeszczak W; Kuźniewicz R; Burak W; Zywiec J; Karasek D; Otulski I; Mosur M
    Med Sci Monit; 2003 Sep; 9(9):CS89-91. PubMed ID: 12960932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis in a patient treated with colchicine and atorvastatin.
    Tufan A; Dede DS; Cavus S; Altintas ND; Iskit AB; Topeli A
    Ann Pharmacother; 2006; 40(7-8):1466-9. PubMed ID: 16772404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masseter muscle rigidity, elevated creatine kinase, and rhabdomyolysis following succinylcholine administration: a case report.
    Fitzpatrick LR
    AANA J; 2008 Oct; 76(5):349-54. PubMed ID: 18947162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rhabdomyolysis caused by pravastatin and type 1 macrocreatine kinase].
    Decoulx E; Millaire A; de Groote P; Mahieux G; Ducloux G
    Ann Cardiol Angeiol (Paris); 1993 May; 42(5):267-9. PubMed ID: 8368799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.